Sermorelin 60mg — Vial Spec, Reconstitution Math & COA

Overview of the Sermorelin 60mg Research Format

Sermorelin is a synthetic 29-amino-acid peptide corresponding to the amino-terminal fragment (GRF 1-29) of endogenous growth hormone-releasing hormone (GHRH). Containing the fully functional catalytic site of native human GHRH, this sequence retains full biological activity at the GHRH receptor (GHRHR) while omitting the non-essential C-terminal sequence (residues 30–44). The 60mg mass representation is engineered to support large-scale laboratory workflows, providing sufficient peptide material to execute multi-well cellular assay series without the inter-vial batch variation inherent to multiple smaller standard vials.

Primary purchasers of 60mg bulk configurations include academic research facilities, contract research organizations (CROs), and analytical laboratories conducting automated receptor-binding screens or extended rodent bio-assay studies. Acquiring high-mass single vials ensures consistent baseline concentration across prolonged experiment timelines, minimizing variance in baseline mass spectrometry readings and target binding kinetics. Researchers seeking standardized single-vial research options for smaller assay sets can explore our core catalog at Sermorelin or browse our complete library of all peptides.

Chemical Structure, Molecular Weight, and Receptor Affinity

Sermorelin acetate possesses the empirical chemical formula C149H246N44O42S with a calculated exact molecular weight of 3357.88 Da. The sequence consists of Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2. In preclinical cell culture systems, Sermorelin functions as a selective GHRH receptor agonist, binding to the G-protein coupled receptor on anterior pituitary somatotroph membranes to activate the adenylate cyclase-CAMP signaling pathway.

In vitro functional assays demonstrate that Sermorelin initiates intracellular calcium mobilization and cyclic adenosine monophosphate (cAMP) accumulation with nanomolar EC50 values comparable to native 44-amino-acid GHRH. Because the peptide lacks the hydrophobic C-terminus of full-length GHRH, its solubility profile in polar aqueous buffers is optimized, enabling rapid dissolution during laboratory reconstitution protocols.

Reconstitution Math and Concentration Calculations

Reconstituting a high-yield 60mg lyophilized cake requires precise diluent calculation to achieve target working stock concentrations for micro-pipetting accuracy. Given the 60mg total mass, adding standard laboratory diluent volumes yields high-density stock solutions optimized for subsequent serial dilution series:

• 1.0 mL Diluent Addition: Yields a final concentration of 60.0 mg/mL (60.0 µg/µL). This hyper-concentrated stock is suitable for master-plate distribution or long-term deep-freeze stock creation, though high solute density requires gentle mixing to ensure full solvation. • 2.0 mL Diluent Addition: Yields a final concentration of 30.0 mg/mL (30.0 µg/µL). Provides an optimal balance between volumetric accuracy and solution viscosity for high-precision auto-samplers. • 3.0 mL Diluent Addition: Yields a final concentration of 20.0 mg/mL (20.0 µg/µL). Ideal for standard volumetric micro-pipetting where microgram-level delivery is required across multiple test wells. • 6.0 mL Diluent Addition (if vial capacity permits): Yields a final concentration of 10.0 mg/mL (10.0 µg/µL), simplifying mathematical conversion during automated liquid handler programming.

To verify customized dilution ratios and calculate exact working concentrations for specific lab protocols, utilize our interactive laboratory reconstitution calculator.

Aliquot Management and Preventing Freeze-Thaw Degradation

Because a 60mg vial contains substantial peptide mass, reconstituting the entire volume for immediate single-use applications is rarely efficient. Solubilized peptides are susceptible to hydrolysis, oxidation of the Methionine-27 residue, and aggregation when subjected to repeated freeze-thaw cycles. Therefore, establishing a systematic aliquot protocol immediately following primary reconstitution is critical for preserving structural integrity.

Upon full dissolution in sterile bacteriostatic water or target assay buffer, the master stock should be aliquoted immediately under aseptic conditions into sterile, low-binding polypropylene micro-centrifuge tubes. Individual aliquot volumes should reflect single-day assay requirements (e.g., 50 µL to 200 µL per tube). Aliquots intended for short-term active use (within 7 to 14 days) may be stored at 2°C to 8°C, while master aliquots reserved for long-term storage must be flash-frozen in liquid nitrogen or ultra-low temperature freezers at -80°C.

Storage Stability: Lyophilized vs. Liquid State

Lyophilized Sermorelin 60mg powder demonstrates high thermodynamic stability when preserved in sealed borosilicate glass vials filled under inert argon atmosphere. Unreconstituted vials stored at -20°C maintain chemical stability and structural purity (>98%) for up to 24 months. For extended archival storage exceeding two years, storage at -80°C in dark, desiccant-controlled conditions is recommended to eliminate ambient humidity degradation.

Once solubilized, the liquid-phase stability of Sermorelin is strictly dependent on temperature, pH, and solvent composition. At 2–8°C in sterile bacteriostatic water containing 0.9% benzyl alcohol, working solutions retain analytical stability for approximately 21–28 days. In non-preserved saline or phosphate-buffered saline (PBS), liquid solutions should be utilized within 24–48 hours to avoid enzymatic breakdown or micro-bacterial proliferation. Never expose reconstituted peptide solutions to ultrasonic agitation or vigorous vortexing, as mechanical shear stress induces protein denaturation.

Lot-Matched Certificate of Analysis (COA) Verification

PX1 Research enforces stringent analytical testing protocols for every production batch. High-mass research products such as Sermorelin 60mg undergo comprehensive quality assurance prior to release, documented in a lot-matched Certificate of Analysis. Every unit dispatched from our California and Arizona logistics centers is verified by independent ISO 17025 accredited laboratories.

Analytical verification parameters reported on each COA include: 1. Purity Analysis by Reverse-Phase HPLC (RP-HPLC): Quantifies peptide purity, enforcing a minimum threshold of >98.0% area under the curve. 2. Molecular Weight Identity by Mass Spectrometry (ESI-MS / MALDI-TOF): Confirms the exact monoisotopic mass matches the theoretical 3357.9 Da signature. 3. Bacterial Endotoxin Testing (Chromogenic LAL Assay): Verifies endotoxin levels remain below strictly monitored research limits (<0.1 EU/mg). 4. Residual Solvent & Heavy Metal Analysis: Ensures complete removal of trifluoroacetic acid (TFA) salts and synthesis reagents.

To review real-time analytical records for current operational lots, access our centralized COA verification hub.

Comparative Analysis: Sermorelin vs. Alternate Growth Hormone Secretagogues

When designing preclinical GH axis stimulation experiments, researchers evaluate distinct classes of secretagogues based on receptor target, signaling kinetics, and half-life dynamics. Sermorelin represents a pure GHRH receptor agonist, whereas other laboratory compounds target distinct pathways or possess structural modifications to alter enzymatic degradation rate.

For example, CJC-1295 Without DAC (MOD GRF 1-29) features four amino acid substitutions (D-Ala2, Gln8, Ala15, Leu27) that confer enhanced resistance to dipeptidyl peptidase-IV (DPP-IV) cleavage compared to native Sermorelin. Alternatively, ghrelin receptor (GHS-R1a) agonists like Ipamorelin and GHRP-2 operate via distinct non-GHRH signaling mechanisms to stimulate growth hormone release without elevating plasma cortisol or prolactin to equivalent degrees. Selecting between native GHRH fragments like Sermorelin and synthetic peptidyl secretagogues depends entirely on whether the experimental protocol focuses on physiological GHRHR signaling or sustained, modified receptor occupancy.

Selecting the Optimal Format: 60mg Bulk Mass vs. Standard Catalog Sizes

Determining whether a 60mg bulk vial format or standard laboratory unit sizes (such as 2mg or 5mg vials) best suits an experimental design involves weighing reconstitution protocols against workflow requirements. If PX1 Research does not currently list an active 60mg individual SKU in the public store, high-volume research facilities requiring bulk batching can obtain equivalent or custom mass yields via our institutional wholesale research program, or deploy multiple standard catalog units available directly at Sermorelin.

• High-Mass (60mg Bulk): Recommended for continuous automated dispensing platforms, multi-plate receptor binding screens, long-term rodent cohort investigations, or shared central facility repositories. Reduces container waste and eliminates lot-to-lot variance across extended experimental timelines. • Standard Catalog Fills (2mg or 5mg): Superior for small-scale pilot studies, short-duration cellular incubations, or protocols where reconstituting small discrete volumes minimizes long-term storage risks. Explore our complete directory of research compounds via the research hub to select the exact quantity suited to your laboratory's operational scope.